SynthesisBMC medicine2011
Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting.
Synthesis in BMC medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05609266 (Validation of Non-invasive Risk Models for Prediction of Incident Type 2 Diabetes in a Swedish Population), which is not on this map. Cited by 229 papers, 39 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Validation of Non-invasive Risk Models for Prediction of Incident Type 2 Diabetes in a Swedish Population
Who cites it
229 citing papers in PubMed, 39 syntheses or guidelines pooled it, 492 citations in OpenAlex.
- Quality and performance of machine learning versus logistic regression for predicting IVIG resistance in Kawasaki disease: a PROBAST+AI systematic comparison.BMC medical research methodology · 2026Pooled it
- Geographic disparities and methodological quality of type 2 diabetes prediction models: a systematic review and meta-analysis of 97 models.BMC endocrine disorders · 2026Pooled it
- Risk prediction models for cancer therapy related cardiac dysfunction in patients with cancer and cancer survivors: systematic review and meta-analysis.BMJ (Clinical research ed.) · 2025Pooled it
- TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods: a Korean translation.Ewha medical journal · 2025Guideline
- Predictive value of machine learning for the progression of gestational diabetes mellitus to type 2 diabetes: a systematic review and meta-analysis.BMC medical informatics and decision making · 2025Pooled it
- Artificial intelligence in the risk prediction models of cardiovascular disease and development of an independent validation screening tool: a systematic review.BMC medicine · 2024Pooled it
- Systematic review of clinical prediction models for psychosis in individuals meeting At Risk Mental State criteria.Frontiers in psychiatry · 2024Pooled it
- Research inefficiencies in external validation studies of the Framingham Wilson coronary heart disease risk rule: A systematic review.PloS one · 2024Pooled it
- Poor handling of continuous predictors in clinical prediction models using logistic regression: a systematic review.Journal of clinical epidemiology · 2023Pooled it
- Causal Model Building in the Context of Cardiac Rehabilitation: A Systematic Review.International journal of environmental research and public health · 2023Pooled it
- Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review.BMC medical research methodology · 2022Pooled it
- Applicability of predictive models for 30-day unplanned hospital readmission risk in paediatrics: a systematic review.BMJ open · 2022Pooled it
- Systematic review of studies examining contribution of oral health variables to risk prediction models for undiagnosed Type 2 diabetes and prediabetes.Clinical and experimental dental research · 2022Pooled it
- Completeness of reporting of clinical prediction models developed using supervised machine learning: a systematic review.BMC medical research methodology · 2022Pooled it
- Reporting of prognostic clinical prediction models based on machine learning methods in oncology needs to be improved.Journal of clinical epidemiology · 2021Pooled it
- Availability and reporting quality of external validations of machine-learning prediction models with orthopedic surgical outcomes: a systematic review.Acta orthopaedica · 2021Pooled it
- Models for estimating and projecting global, regional and national prevalence and disease burden of asthma: a systematic review.Journal of global health · 2020Pooled it
- Risk Prediction Models for Melanoma: A Systematic Review on the Heterogeneity in Model Development and Validation.International journal of environmental research and public health · 2020Pooled it
- Early warning scores for detecting deterioration in adult hospital patients: systematic review and critical appraisal of methodology.BMJ (Clinical research ed.) · 2020Pooled it
- FINDRISC in Latin America: a systematic review of diagnosis and prognosis models.BMJ open diabetes research & care · 2020Pooled it
169 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
backgroundThe World Health Organisation estimates that by 2030 there will be approximately 350 million people with type 2 diabetes. Associated with renal complications, heart disease, stroke and peripheral vascular disease, early identification of patients with undiagnosed type 2 diabetes or those at an increased risk of developing type 2 diabetes is an important challenge. We sought to systematically review and critically assess the conduct and reporting of methods used to develop risk prediction models for predicting the risk of having undiagnosed (prevalent) or future risk of developing (incident) type 2 diabetes in adults.
methodsWe conducted a systematic search of PubMed and EMBASE databases to identify studies published before May 2011 that describe the development of models combining two or more variables to predict the risk of prevalent or incident type 2 diabetes. We extracted key information that describes aspects of developing a prediction model including study design, sample size and number of events, outcome definition, risk predictor selection and coding, missing data, model-building strategies and aspects of performance.
resultsThirty-nine studies comprising 43 risk prediction models were included. Seventeen studies (44%) reported the development of models to predict incident type 2 diabetes, whilst 15 studies (38%) described the derivation of models to predict prevalent type 2 diabetes. In nine studies (23%), the number of events per variable was less than ten, whilst in fourteen studies there was insufficient information reported for this measure to be calculated. The number of candidate risk predictors ranged from four to sixty-four, and in seven studies it was unclear how many risk predictors were considered. A method, not recommended to select risk predictors for inclusion in the multivariate model, using statistical significance from univariate screening was carried out in eight studies (21%), whilst the selection procedure was unclear in ten studies (26%). Twenty-one risk prediction models (49%) were developed by categorising all continuous risk predictors. The treatment and handling of missing data were not reported in 16 studies (41%).
conclusionsWe found widespread use of poor methods that could jeopardise model development, including univariate pre-screening of variables, categorisation of continuous risk predictors and poor handling of missing data. The use of poor methods affects the reliability of the prediction model and ultimately compromises the accuracy of the probability estimates of having undiagnosed type 2 diabetes or the predicted risk of developing type 2 diabetes. In addition, many studies were characterised by a generally poor level of reporting, with many key details to objectively judge the usefulness of the models often omitted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.